Effective oral nasal decongestion. A double-blind, crossover analysis.
D000605:Amino Alcohols / Q000627:therapeutic use; D001966:Bromine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004809:Ephedrine / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D014663:Nasal Decongestants / Q000627:therapeutic use*; D010627:Phenethylamines / Q000627:therapeutic use; D010632:Pheniramine / Q000627:therapeutic use; D010665:Phenylpropanolamine / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D013566:Sympathomimetics / Q000627:therapeutic use
D000605:Amino Alcohols; D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants; D010627:Phenethylamines; D011725:Pyridines; D013566:Sympathomimetics; D010632:Pheniramine; D010665:Phenylpropanolamine; D004809:Ephedrine; D001966:Bromine